(Q47702951)

4 February 2018

title

Influence of lipoprotein(a) plasma concentration on neointimal growth in a monkey model of vascular injury (English)

1 reference

4 February 2018

1 reference

Ryan MJ

1

1 reference

4 February 2018

Emig LL

2

1 reference

4 February 2018

Hicks GW

3

1 reference

4 February 2018

Ramharack R

4

1 reference

4 February 2018

Brammer DW

5

1 reference

4 February 2018

Gordon D

6

1 reference

4 February 2018

Auerbach BJ

7

1 reference

4 February 2018

Keiser JA

8

1 reference

4 February 2018

publication date

1 July 1998

1 reference

4 February 2018

published in

Atherosclerosis

1 reference

4 February 2018

volume

139

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

137-145

1 reference

4 February 2018

Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Lipoprotein(a) as a determinant of coronary heart disease in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Lp(a) lipoprotein as a risk factor for myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Lipoprotein Lp(a) and the risk for myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Proliferation of human smooth muscle cells promoted by lipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

In Vivo Transfer of Lipoprotein(a) Into Human Atherosclerotic Carotid Arterial Intima

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Occlusive arterial thrombosis in cynomolgus monkeys with varying plasma concentrations of lipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Localization of lipoprotein(a) in a monkey model of rapid neointimal growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Kringle-dependent structural and functional polymorphism of apolipoprotein (a).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

The restenosis paradigm revisited: an alternative proposal for cellular mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

Lipoprotein(a) in diet-induced atherosclerosis in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900072-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(98)00072-0

1 reference

4 February 2018

1 reference

4 February 2018